Mexico to India: Syringe Import Trade Route

The Mexico to India Syringe corridor is one of India's established pharmaceutical import routes from Mexico, with 38 shipments documented worth a combined $1.9M USD. The route is dominated by ORMCO CORPORATION , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Mexico's syringe export sector.

Across 1 active Mexico suppliers, the average shipment value stands at $49.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 22.3%, placing it at rank #12 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include NOBEL BIOCARE INDIA PRIVATE LIMITED . NOBEL BIOCARE INDIA PRIVATE LIMITED is the single largest Indian importer with 38 shipments valued at $1.9M USD.

India's syringe imports from Mexico are driven primarily by a handful of large-scale Mexico manufacturers. ORMCO CORPORATION with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Mexico supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ORMCO CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $49.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as refill syringe -enlight kerr 28713 2-1371 30 and refill syringe -enlight kerr 28713 2-1371 usd , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Mexico supplier.

On the buying side, NOBEL BIOCARE INDIA PRIVATE LIMITED is the largest importer with 38 shipments worth $1.9M USD — representing 100% of all syringe imports from Mexico on this route.